Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001213900-25-085280
Filing Date
2025-09-08
Accepted
2025-09-08 07:02:34
Documents
1
Period of Report
2025-08-29

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 3620
  Complete submission text file 0001213900-25-085280.txt   5080
Mailing Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4200 BERKELEY HEIGHTS NJ 07922 908-517-9500
CorMedix Inc. (Issuer) CIK: 0001410098 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O CORMEDIX INC. 300 CONNELL DRIVE, SUITE 4200 BERKELEY HEIGHTS NJ 07922
Business Address
Zelnick Kaufman Beth (Reporting) CIK: 0002004480 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34673 | Film No.: 251298529